Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sickness funds hamper innovation, claim doctors

This article was originally published in Clinica

Executive Summary

"The statutory health insurers are not prepared to finance new treatments. They want doctors to finance these from their own pocket and that is wholly unacceptable," says Dr Manfred Richter-Reichhelm, principal chairman of the federal association of statutory healthcare physicians (KBV). Speaking after a meeting between the sickness funds and his association, he pointed out that within the next three years the financial volume of innovative procedures would reach DM1.5 billion. It was for this reason that Dr Richter-Reichhelm believed that the sickness funds must change their hostile attitude towards their insured clients.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel